PMID: 7018426Jun 1, 1981Paper

Renal transplantation after thoracic duct drainage

Annals of Surgery
J C FishM W Flye

Abstract

Forty-seven patients treated by at least 28 days of thoracic duct drainage (TDD) before cadaveric renal transplant are compared with 63 patients treated with standard immunosuppression. The TDD patients were begun on half the dosage of steroids, and at 30 days were receiving approximately two-thirds the dose that the non-TDD patients received. Acute rejection occurred in 35% of the TDD group, as compared with 61% of the non-TDD group. Graft survival in the TDD patients was twice as good as the non-TDD patients at all time intervals. The patient survival rates were not significantly different between the two groups. TDD pretransplant favorably affects cadaveric renal allograft survival for at least five years.

Citations

Dec 20, 2017·Cardiovascular and Interventional Radiology·Maxim Itkin, Gregory J Nadolski
Aug 2, 2003·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Satoshi AikoTadaaki Maehara
Oct 9, 2015·Obesity Surgery·Barak RosenzweigAviv Shaish
Oct 31, 2001·The British Journal of Surgery·S A Wemyss-HoldenG J Maddern
Jul 25, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Kate J BurettaJustin M Sacks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.